Association between existence of integrons and multi-drug resistance in Acinetobacter isolated from patients in Southern Iran

• Autorzy: Japoni S. , Japoni A. , Farshad S. , Ali A. A. , Jamalidoust M.
• Języki publikacji: EN

Abstrakty

EN

Nosocomial infections caused by multi-drug resistant Acinetobacter pose a serious problem in many countries. This study aimed at determining the antibiotic susceptibility patterns and prevalence of different classes of integrons in isolated Acinetobacter. In addition, the association between production of specific bands in PCR assay and magnitude of multi-drug resistance was investigated. In total, 88 Acinetobacter strains were isolated from patients from October 2008 through September 2009. The Minimal inhibitory concentration (MIC) of 12 antibiotics conventionally used in clinics against the isolates, was determined by E-test method. The existence of integron classes was investigated by PCR assay through the amplification of integrase genes. The most effective antibiotic against Acinetobacter was colistin with 97.7% activity, followed by imipenem (77.3%) and meropenem (72.7%). The presence of integron classes 1 and 2 in 47 (53.4%) isolates was confirme, However, no class 3 was detected. The proportion of class 1, compared with class 2, was high (47.7% vs. 3.4%). The association between multi-drug resistance to norfloxacin, ceftazidime, gentamicin, ciprofloxacin, cefepime and amikacin and the presence of integrons was statistically significant. However, the association was not remarkable in many of the isolates which exhibited resistance to the rest of antibiotics. This may imply that in addition to integrons, other resistance determinants such as transposon and plasmid may also contribute to resistance. To reduce the pressure on sensitive isolates, comprehensive control measures should be implemented. Furthermore, wise application of effective antibiotics could help alleviate the situation. Colistin is the most effective antibiotic in vitro against Acinetobacter.

Słowa kluczowe

EN

integron; multidrug resistance; Acinetobacter; isolation; patient; polymerase chain reaction; nosocomial infection; bacteria; Iran

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2011
• Tom: 60
• Numer: 2
• Opis fizyczny: p.163-168,fig.,ref.

Twórcy

autor

Japoni S.

• Department of Biology, Alzahra University, Tehran, Iran

autor

Japoni A.

autor

Farshad S.

autor

Ali A. A.

autor

Jamalidoust M.

Bibliografia

• Arakawa Y., M. Murakami, K. Suzuki, H. Ito, R. Wacharotayankun, S. Ohsuka, N. Kato and M. Ohta, M. 1995. A novel integron-like element carrying the metallo-b-lactamase gene blaIMP. Antimicrob. Agents. Chemother. 39: 1612–1615.
• Bergogne-Berezin E. and K.J. Towner. 1996. Acinetobacter spp. as nosocomial pathogens: Microbiological, clinical & epidemiological features. Clin. Microbiol. 8: 148–165.
• Chen T.L., W.C. Chang, S.C. Kuo, Y.T. Lee, C.P. Chen, L.K. Siu, W.L. Cho and C.P. Fung. 2010. Contribution of a plasmid borne blaOXA-58 with its hybrid promoter provided by IS1006 and ISAba3-like to {beta}-lactam resistance in Acinetobacter genomic species 13TU. Antimicrob. Agents. Chemother. 54: 3107–3112.
• Feizabadi M.M., B. Fatollahzadeh, M. Taherikalani, M. Rasoolinejad, N. Sadeghiferd, M. Aligholi, S. Soroush and S. Mohammadi-Yegane. 2008. Antimicrobial susceptibility patterns and distribution of bla OXA genes among Acinetobacter spp. isolated from patients at Tehran hospitals. Jpn. J. Infect. Dis. 61: 274–278.
• Galleco L. and K.J Towner. 2001. Carriage of class 1 integrons and antibiotic resistance in clinical isolates of Acinetobacter baumannii from Northern Spain. J. Med. Microbiol. 50: 71–77.
• Gaur A., P. Prakash, S. Anupurba and T.M. Mahapatra. 2006. Possible role of integrase gene polymerase chain reaction as an epidemiological marker: study of multi-drug resistant Acinetobacter baumannii isolated from nosocomial infections. Int. J. Antimicrobial. Agents. 29: 446–450.
• Gisneous J.M. and J. Rodriguez-Bano. 2002. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin. Microbiol. Infects. 8: 687–693.
• Gonzalez G., K. Sossa, H. Bello, M. Dominguez, S. Mella and R. Zemelman. 1998. Presence of integrons in isolates of different biotypes of Acinetobacter baumannii from Chilean hospitals. FEMs. Microbiol. lett. 161: 125–128.
• Koeleman J.G., J. Stoof, M.W. Van Der bijl, C. M.VandenbrouckeGrauls and P.H. Savelkoul. 2000. Identification of epidemic strains of Acinetobacter baumannii by integrase gene PCR. J. Clin. Microbiol. 39: 8–13.
• Lévesque C., L. Piché, C. Larose and P.H. Roy. 1995. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob. Agents. Chemother. 39: 185–91.
• Lewis J.R. and S.A. Lewis. 2004. Colistin interactions with mammalian urothelium. Am. J. physiol. Cell. physiol. 286: C913– C922.
• Neild B.S., A.J. Holmes, M.R. Gillings, G.D. Recchia, , B.C. Mabbutt, K.M. Nevalainen and H.W. Stokes. 2001. Recovery of new integron classes from environmental DNA. FEMS. Microbiol. Lett. 195: 59–65.
• Nordmann P. 2004. Acinetobacter baumannii, the nosocomial pathogen par excellence. Pathol. Biol. 52: 301–303.
• Perez F., A.M. Hujer, K.M. Hujer, B.K. Decker, P.N. Rather and R.A. Bonomo. 2007. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents. Chemother. 51: 3471–3484.
• Ploy M.C., F. Denis, P. Courvalin and T. Lambert. 2000. Molecular characterization of integrons in Acinetobacter baumannii: description of a hybrid class 2 integron. Antimicrob. Agents. Chemother. 44: 2684–2688.
• Radström P., O. Sköld, G. Swedberg, J. Flensburg, P.H. Roy and L. Sundström. 1994. Transposon Tn5090 of plasmid R751, which carries an integron, is related to Tn7, Mu, and the retroelements. J. Bacteriol. 176: 3257–3268.
• Reed M.D., R.C. Stern, M.A. O’Riordan and J.L. Blumer. 2001. The pharmacokinetics of colistin in patients with cystic fibrosis. J. Clin. Pharmacol. 41: 645–54.
• Rowe-Magnus D. A. and D. Mazel. 1999. Resistance gene capture. Curr. Opin. Microbiol. 2: 481–486.
• Seifert H., R. Baginsky, A. Schulze and G. Polverer. 1993. The distribution of Acinetobacter species in clinical culture materials. Zentralbl. Bakteriol. 279: 544–552.
• Seward R.J. 1999. Detection of integrons in worldwide nosocomial isolates of Acinetobacter spp. Clin. Microbiol. Infect. 5: 308–318.
• Towner K.J. 2009. Acinetobacter: an old friend, but a new enemy. J. Hosp. Infect. 73: 355–63.
• Turton J.F., M.E. Kaufmann, J. Glover, J.M. Coelho, M. Warner, R. Pike and T.L. Pitt. 2005. Detection and typing of integrons in epidemic strains of Acinetobacter baumannii found in the United Kingdom. J. Clin. Microbiol. 43: 3074–3082.
• Villegas M.V. and A.I. Hartstein. 2003. Acinetobacter outbreaks, 1977–2000. Infect. Control. Hosp. Epidemiol. 24: 284–95.
• Xu X., F. Kong, X. Cheng, B. Yan X. Du, J. Gai, H.Ai, L. Shi and J. Iredell. 2008. Integron gene Cassettes in Acinetobacter spp. Strains from south China”. Int. J. Antimicrobial. Agents. 32: 441–445.